In a filing, Viking Therapeutics Inc revealed its Director SINGLETON J MATTHEW unloaded Company’s shares for reported $0.72 million on Sep 20 ’24. In the deal valued at $69.50 per share,10,300 shares were sold. As a result of this transaction, SINGLETON J MATTHEW now holds 9,500 shares worth roughly $0.61 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Lian Brian sold 216,130 shares, generating $15,308,553 in total proceeds. Upon selling the shares at $70.83, the President & CEO now owns 2,304,927 shares.
Before that, Lian Brian bought 216,130 shares. Viking Therapeutics Inc shares valued at $3,978,372 were divested by the Officer at a price of $18.41 per share.
JP Morgan initiated its Viking Therapeutics Inc [VKTX] rating to an Overweight in a research note published on September 11, 2024; the price target was $80. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who began to cover the stock in late June with a ‘”an Overweight”‘ rating. Raymond James also remained covering VKTX and has increased its forecast on May 16, 2024 with a “Strong buy” recommendation from previously “an Outperform” rating. Oppenheimer maintained its rating on March 26, 2024. It rated VKTX as “an Outperform”.
Price Performance Review of VKTX
On Monday, Viking Therapeutics Inc [NASDAQ:VKTX] saw its stock fall -2.22% to $64.34. Over the last five days, the stock has lost -2.22%. Viking Therapeutics Inc shares have risen nearly 245.73% since the year began. Nevertheless, the stocks have risen 537.03% over the past one year. While a 52-week high of $99.41 was reached on 02/28/24, a 52-week low of $8.28 was recorded on 01/03/24. SMA at 50 days reached $62.65, while 200 days put it at $57.56.
Levels Of Support And Resistance For VKTX Stock
The 24-hour chart illustrates a support level at 63.36, which if violated will result in even more drops to 62.37. On the upside, there is a resistance level at 65.80. A further resistance level may holdings at 67.25. The Relative Strength Index (RSI) on the 14-day chart is 51.05, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.19, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 58.20%. Stochastics %K at 51.76% indicates the stock is a holding.
How much short interest is there in Viking Therapeutics Inc?
A steep rise in short interest was recorded in Viking Therapeutics Inc stocks on 2024-09-30, dropping by -2.66 million shares to a total of 14.48 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 17.14 million shares. There was a decline of -18.38%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on March 07, 2024 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $110 price target.
